AVTX Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Avalo Therapeutics Inc

Watchlist Manager

Watchlist

Price: 16.02 USD -2.02% Market Closed

Market Cap: $842.1m

	Avalo Therapeutics Inc NASDAQ:AVTX	US
	Societe Generale SA PAR:GLE	FR
	Planet Fitness Inc NYSE:PLNT	US

Profitability Summary

Avalo Therapeutics Inc's profitability score is 24/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

100%

Strong 3Y Average Gross Margin

105%

Gross Margin is Increasing

81% > 100%

Negative Operating Margin

-123.602%

Negative 3Y Average Operating Margin

-18.716%

Declining Operating Margin

-146% > -123.602%

Negative Net Margin

-132.642%

Negative 3Y Average Net Margin

-21.305%

Declining Net Margin

-170% > -132.642%

Negative Free Cash Flow Margin

-87.217%

Negative 3Y Average Free Cash Flow Margin

-14.686%

Declining Free Cash Flow Margin

-121% > -87.217%

Negative ROE

-72%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-281%

Declining ROIC

-151% > -428%

View All

Hide

Collapse

24 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.